APA

Gurumurthy P., Ramachandran G., Hemanth Kumar A. K., Rajasekaran S., Padmapriyadarsini C., Swaminathan S., Bhagavathy S., Venkatesan P., Sekar L., Mahilmaran A., Ravichandran N. & Paramesh P. (20041221). Decreased bioavailability of rifampin and other antituberculosis drugs in patients with advanced human immunodeficiency virus disease. : Antimicrobial agents and chemotherapy.

Chicago

Gurumurthy Prema, Ramachandran Geetha, Hemanth Kumar A K, Rajasekaran S, Padmapriyadarsini C, Swaminathan Soumya, Bhagavathy S, Venkatesan P, Sekar L, Mahilmaran A, Ravichandran N and Paramesh P. 20041221. Decreased bioavailability of rifampin and other antituberculosis drugs in patients with advanced human immunodeficiency virus disease. : Antimicrobial agents and chemotherapy.

Harvard

Gurumurthy P., Ramachandran G., Hemanth Kumar A. K., Rajasekaran S., Padmapriyadarsini C., Swaminathan S., Bhagavathy S., Venkatesan P., Sekar L., Mahilmaran A., Ravichandran N. and Paramesh P. (20041221). Decreased bioavailability of rifampin and other antituberculosis drugs in patients with advanced human immunodeficiency virus disease. : Antimicrobial agents and chemotherapy.

MLA

Gurumurthy Prema, Ramachandran Geetha, Hemanth Kumar A K, Rajasekaran S, Padmapriyadarsini C, Swaminathan Soumya, Bhagavathy S, Venkatesan P, Sekar L, Mahilmaran A, Ravichandran N and Paramesh P. Decreased bioavailability of rifampin and other antituberculosis drugs in patients with advanced human immunodeficiency virus disease. : Antimicrobial agents and chemotherapy. 20041221.